Navigation Links
Dr. Renu Razdan of Max Neeman International Appointed Vice Chairman, ACRO India
Date:12/5/2013

RESEARCH TRIANGLE PARK, N.C., Dec. 5, 2013 /PRNewswire/ -- The Association of Contract Research Organizations [ACRO] India has appointed Max Neeman's Chief Operating Officer, Dr. Renu Razdan as Vice Chairman. The appointment is effective immediately with key responsibility to create and strengthen the network with regulatory agencies, law makers and scientific community in India.

Max Neeman, a leading Indian provider of clinical research services to the pharmaceutical, biotech and medical device industry for over 10 years, promoted Dr. Razdan to COO in 2009. Prior to joining the company, she worked at Ranbaxy Laboratories Limited as Senior Manager Business Development then Head of Exports, and has also worked with Transasia Biomedicals and HPCL Systems.

Dr. Razdan holds a PhD in Biochemistry from German Cancer Research Centre (DKFZ), Heidelberg, Germany and has been featured as a prominent female achiever in the Life Sciences community; November 2010 issue of 'BioSpectrum India' life science journal.

When asked what she hopes to achieve, Dr. Razdan's response was twofold: 1) to strengthen the channels of communication between industry, regulators and other stakeholders for drug development in India 2) focus on promoting India as a place where good drug development research takes place, despite recent challenges.

About Max Neeman International
'Max Neeman' is a leading Asia-Pacific CRO with India expertise and expanded capabilities into N. America and Europe. Since 2001, the company has provided clinical research services for the successful conduct of drug and device trials in compliance with ICH GCP standards. The company is ISO 9001:2008 certified for monitoring, site management and data management with over >400 employees, 245 active sites in various therapeutic areas and 310 trials awarded. Data Management services alone have touched 60 countries. For more information contact Donald Swankie, Vice President USA:  919.424.3345, donald.swankie@neeman-medical.com or go to www.neeman-medical.com.

About ACRO
ACRO is an independent, non-profit organization with a global perspective. ACRO India, founded and registered in India in Feb 2005, has been formed under the aegis of Confederation of Indian Industry (CII) for bringing all CRO's operating in India on one common platform. With its vision of establishing India as a global sourcing hub for Contract Research, ACRO is used to promote quality research, uphold ethics, share best practices, promote synergies amongst members, to deliberate and act upon common concerns, especially with regards to Indian regulations and industry environment.


'/>"/>
SOURCE Max Neeman International
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. UV Flu Technologies Expands Its International Footprint
2. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
3. International Attendance for Networking and Education at Informex Beyond Manufacturing
4. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
5. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
6. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
7. PAREXEL International to Present at J.P. Morgan Healthcare Conference
8. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
9. Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease
10. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
11. BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... NEWTOWN SQUARE, Pa. , June 20, 2017 /PRNewswire/ ... technology, is pleased to announce the issuance of a ... treating gout or hyperuricemia by the U.S. Patent and ... Biotech Inc., a winner of the Buzz of Bio ... , is akin to developing non-drug approaches to ...
(Date:6/19/2017)... ... June 19, 2017 , ... EDETEK, Inc., a ... that it is launching two new additions of its award-winning cloud-based platform CONFORM™: ... at the DIA 2017 Annual Meeting in Chicago, IL, June 19-22, 2017. , ...
(Date:6/16/2017)... ... ... CTNext , Connecticut’s go-to resource for entrepreneurial support, today announced the ... Piers in Stamford. , Nine finalists, all of whom are Connecticut-based companies and entrepreneurs, ... secure $10,000 awards to help support business growth. The winners included:, ...
(Date:6/15/2017)... , ... June 15, 2017 , ... ... director for DuPont Biofuels, will be speaking at Bloomberg’s 2017 Sustainable Business ... join other leading environmental and sustainability officials on a panel titled “Developing a ...
Breaking Biology Technology:
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
(Date:3/28/2017)... -- The report "Video Surveillance Market by ... Devices), Software (Video Analytics, VMS), and Service (VSaaS, Installation ... 2022", published by MarketsandMarkets, the market was valued at ... reach USD 75.64 Billion by 2022, at a CAGR ... considered for the study is 2016 and the forecast ...
Breaking Biology News(10 mins):